The National Asthma Council Logo

 

 

Leading the attack against asthma

Search website
Home About the NAC Strategy Managing Asthma Research Emergency
 
Asthma information Papers
 
Asthma Management Handbook Asthma Action Plans Spirometry Resources  Other Resources Information Papers Special Topics Professional Development  

Asthma Information Papers

Roles of influenza and pneumococcal vaccinations
Influenza vaccination overview
Case for Influenza Vaccination
Potential benefits for people with asthma
Potential benefits for people with COPD
Potential benefits for people with cardiovascular disease
Potential benefits for people with diabetes
Pneumococcal vaccination overview
Case for Pneumococcal Vaccination
Potential benefits in specific high-risk groups
References
Content created May 2005
Page updated Feb 2006


Get Adobe Reader

Get Adobe Flash Player

 

NextBackPeople with diabetes

Potential benefits in specific high-risk groups

During influenza outbreaks, mortality in people with diabetes may rise by 5-15%, particularly in those with complications such as cardiac and renal disease.25,26 The increased risk of morbidity and mortality in people with diabetes may be influenced by concomitant cardiovascular disease or older age, but the incidence of diabetic ketoacidosis and an impaired immune response to influenza virus and Staphylococcus aureus suggest that diabetes itself is a risk factor for serious complications.25 People with diabetes may have an abnormality of their immune system that makes them more susceptible to infection, but they appear to generate the necessary immune response to vaccination.26

 

Observational studies suggest that influenza vaccination reduces hospitalisation and death associated with influenza in people with diabetes during the period immediately preceding an epidemic,10,11 however, randomised controlled data in this area are lacking.

 

Implications for Australian practice

  • All people aged 6 months and older with diabetes should receive annual influenza vaccination.

Contraindications to influenza vaccination1

  • Severe allergy to eggs, causing an anaphylactic reaction.
     

  • Severe allergy to any of the products in the vaccines, causing an anaphylactic reaction.
     

  • An illness with fever over 38.5°C. Flu vaccine can be given once the fever and symptoms of the illness have settled down. Flu vaccine can also be given to people if they have a minor illness without a fever.
     

  • History of Guillain-Barre Syndrome which first appeared around the time of a flu vaccination.

Please review the product information before prescribing any influenza vaccination.